Top Markets
Coin of the day
N4 Pharma Plc N4 Pharma Plc

N4 Pharma Plc

N4P
Rank in Stocks #20665
N4 Pharma Plc, a specialist pharmaceutical company, develops novel silica... N4 Pharma Plc, a specialist pharmaceutical company, develops novel silica nanoparticle delivery system for pharmaceutical and biotechnology companies in the United Kingdom. It develops Nuvec, a non-viral adjuvant delivery system for vaccines and cancer treatments. N4 Pharma Plc was incorporated in 1979 and is based in London, the United Kingdom.
Share Price
$0.00646333
Market Cap
$53.79K
Change (1 day)
0.00%
Change (1 year)
4.94%
Country
GB
Trade N4 Pharma Plc (N4P)

Category

Revenue for N4 Pharma Plc (N4P)
Revenue in Jun 2025 TTM: $9.70K
According to N4 Pharma Plc latest financial reports the company's current revenue (TTM) is $9.70K. In 2023 the company made a revenue of $2.49K an increase over the revenue in the year 2022 that was 0.00. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for N4 Pharma Plc from 2000 to 2026
Revenue at the end of each year
Year Revenue Change
2026 (TTM) $9.70K 6.18%
2024 $9.14K 267.54%
2023 $2.49K 0.00%
2022 0.00 0.00%
2021 0.00 0.00%
2020 0.00 0.00%
2019 0.00 0.00%
2018 0.00 0.00%
2017 0.00 -100.00%
2016 $1.43M 0.00%
2015 0.00 -100.00%
2014 $2.13M -43.25%
2013 $3.74M -13.80%
2012 $4.34M -5.75%
2011 $4.61M 54.31%
2010 $2.99M -1.15%
2009 $3.02M 4.69%
2008 $2.89M -7.38%
2007 $3.12M 13.68%
2006 $2.74M 48.32%
2005 $1.85M -42.04%
2004 $3.19M 0.79%
2003 $3.16M -3.07%
2002 $3.26M -48.87%
2001 $6.38M -38.50%
2000 $10.38M 0.00%
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
$24.76B 255,153,815.88%
DE
$4.43B 45,703,347.75%
FR
$28.60B 294,736,107.77%
JP
$9.47B 97,573,908.37%
US
$25.92B 267,149,409.03%
GB